Works matching Bristol-Myers Co.

Results: 641

BRISTOL-MYERS SQUIBB Co. v. PHARMACHEMIE B. V 361 F3d 1343 (Fed. Cir.), rehearing en banc denied, 2004 U.S. App. LEXIS 10300 (Fed. Cir. Apr. 21, 2004).

Published in:: Berkeley Technology Law Journal, 2005, v. 20, n. 1, p. 174
Publication type:: Article

MAINTAINING DUE PROCESS BY EXTENDING BRISTOL-MYERS SQUIBB CO. TO FEDERAL CLASS ACTIONS.

Published in:

American University Law Review, 2023, v. 73, n. 1, p. 293

By:

SYCH, FELICIA D.

Publication type:

Article

Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County: AN EXPLORATION OF THE "ARISES OUT OF" PRONG IN PERSONAL JURISDICTION.

Published in:

Mississippi College Law Review, 2019, v. 37, n. 3, p. 245

By:

Walker, Loden

Publication type:

Article

BRISTOL-MYERS SQUIBB CO. v. SUPERIOR COURT: REPROACHING THE SLIDING SCALE APPROACH FOR THE FIXABLE FAULT OF SLIDING TOO FAR.

Published in:

Maryland Law Review, 2018, v. 77, n. 3, p. 862

By:

FELICCIA, JOHN V.

Publication type:

Article

A Mild and Efficient Synthesis of Oxindoles: Progress Towards the Synthesis of Welwitindolinone A Isonitrile ( We gratefully acknowledge financial support from Yamanouchi, Merck, Pfizer, and Amgen. J.M.R. is the recipient of an NIH postdoctoral fellowship. K.R. thanks Sankyo Co., LTD.; M.H. thanks Daiso Co., LTD., M.M.W. thanks Bristol Myers Squibb for a graduate fellowship. )

Published in:

Angewandte Chemie, 2004, v. 116, n. 10, p. 1290

By:

Joseph M. Ready;
Sarah E. Reisman;
Makoto Hirata;
Matthew M. Weiss;
Kazuhiko Tamaki;
Timo V. Ovaska;
John L. Wood

Publication type:

Article

A Mild and Efficient Synthesis of Oxindoles: Progress Towards the Synthesis of Welwitindolinone A Isonitrile ( We gratefully acknowledge financial support from Yamanouchi, Merck, Pfizer, and Amgen. J.M.R. is the recipient of an NIH postdoctoral fellowship. K.R. thanks Sankyo Co., LTD.; M.H. thanks Daiso Co., LTD., M.M.W. thanks Bristol Myers Squibb for a graduate fellowship. )

Published in:

Angewandte Chemie International Edition, 2004, v. 43, n. 10, p. 1270, doi. 10.1002/anie.200353282

By:

Joseph M. Ready;
Sarah E. Reisman;
Makoto Hirata;
Matthew M. Weiss;
Kazuhiko Tamaki;
Timo V. Ovaska;
John L. Wood

Publication type:

Article

BRISTOL-MYERS SQUIBB CO. V. SUPERIOR COURT OF CALIFORNIA, SAN FRANCISCO COUNTY, ET AL: A DEATH KNELL FOR NATIONWIDE CLASS ACTIONS?

Published in:

University of Cincinnati Law Review, 2018, v. 87, n. 3, p. 829

By:

McClellan, Annie

Publication type:

Article

Access to hepatitis C medicines.

Published in:

Bulletin of the World Health Organization, 2015, v. 93, n. 11, p. 799, doi. 10.2471/BLT.15.157784

By:

Edwards, Danny J.;
Coppens, Delphi G. M.;
Prasad, Tara L.;
Rook, Laurien A.;
Iyera, Jayasree K.

Publication type:

Article

THE WEATHERVANE.

Published in:: Hawaii Journal of Medicine & Public Health, 2013, v. 72, n. 1, p. 34
Publication type:: Article

News and Views.

Published in:

Diabetes, Obesity & Metabolism, 2014, v. 16, n. 3, p. 286, doi. 10.1111/dom.12265

By:

Idris, Iskandar

Publication type:

Article

Violation of homogeneity: a methodologic issue in the use of data mining tools.

Published in:

2003

By:

Lilienfeld, David E.;
Nicholas, Savian;
Macneil, Daniel J.;
Kurjatkin, Olga;
Gelardin, Thomas;
Lilienfeld, David;
Macneil, Daniel

Publication type:

commentary

First-in-class biologic to enter rheumatoid arthritis fray.

Published in:

Nature Biotechnology, 2005, v. 23, n. 11, p. 1323, doi. 10.1038/nbt1105-1323

By:

Garber, Ken

Publication type:

Article

People.

Published in:: Nature Biotechnology, 2005, v. 23, n. 2, p. 249, doi. 10.1038/nbt0205-249
Publication type:: Article

BUSINESS AND REGULATORY NEWS.

Published in:: Nature Biotechnology, 2002, v. 20, n. 12, p. 1181
Publication type:: Article

Entremed's stock seesaws.

Published in:

Nature Biotechnology, 1999, v. 17, n. 3, p. 212, doi. 10.1038/6923

By:

Dorey, Emma

Publication type:

Article

US FDA Clears Bristol-Myers New Drug for Chronic Hepatitis B.

Published in:: Clinical Infectious Diseases, 2005, v. 40, n. 10, p. 1
Publication type:: Article

Barr Says FDA Approves Generic Version of Anti-HIV Drug.

Published in:: Clinical Infectious Diseases, 2005, v. 40, n. 2, p. 1
Publication type:: Article

GILEAD, MERCK, BRISTOL-MYERS TO COMBINE HIV DRUGS.

Published in:: Clinical Infectious Diseases, 2004, v. 39, n. 1, p. iv
Publication type:: Article

FROM CONTACTS TO RELATEDNESS: INVIGORATING THE PROMISE OF "FAIR PLAY AND SUBSTANTIAL JUSTICE" IN PERSONAL JURISDICTION DOCTRINE.

Published in:

Alabama Law Review, 2022, v. 73, n. 3, p. 583

By:

Freer, Richard D.

Publication type:

Article

MISGUIDED PANIC AND MISSED OPPORTUNITY FOR PHARMACEUTICAL INVENTIONS: HOW UNEXPECTED RESULTS ECLIPSED REASONABLE EXPECTATION OF SUCCESS IN BMS V. TEVA.

Published in:

Berkeley Technology Law Journal, 2016, v. 31, p. 587, doi. 10.15779/Z38C85X

By:

Pride, Christelle K.

Publication type:

Article

MYLAN PHARMACEUTICALS, INC. V. THOMPSON.

Published in:: Berkeley Technology Law Journal, 2002, v. 17, n. 1, p. 155
Publication type:: Article

lpilimumab.

Published in:: 2011
Publication type:: Product Review

Apixaban.

Published in:: 2011
Publication type:: Product Review

Saxagliptin.

Published in:: Australian Prescriber, 2011, v. 34, n. 3, p. 89
Publication type:: Article

In brief.

Published in:: Nature, 2007, v. 447, n. 7148, p. 1045, doi. 10.1038/4471045a
Publication type:: Article

A merger too far?

Published in:

Nature, 2007, v. 446, n. 7131, p. 15, doi. 10.1038/446015a

By:

Wadman, Meredith

Publication type:

Article

Supreme Court Strikes Another Blow to Litigation Tourism in Bristol-Myers Squibb.

Published in:

Defense Counsel Journal, 2018, v. 85, n. 2, p. 1

By:

Mellow, Mary Anne;
Walsh, Steven T.;
Tevlin, Timothy R.

Publication type:

Article

The Bad Faith Exception to the One Year Bar to Removal Based on Diversity Jurisdiction.

Published in:

Defense Counsel Journal, 2018, v. 85, n. 1, p. 1

By:

Prost, Mark A.;
Walsh, Steve

Publication type:

Article

Supreme Court Narrows the Landscape for Personal Jurisdiction.

Published in:

Defense Counsel Journal, 2018, v. 85, n. 1, p. 1

By:

Boschert, Neville H.;
Harris, Andrew S.

Publication type:

Article

Abilify approved by the US FDA for add-on treatment of major depressive disorder.

Published in:: Expert Review of Neurotherapeutics, 2008, v. 8, n. 1, p. 7
Publication type:: Article

The 2005 Tour of Hope.

Published in:: Nursing Education Perspectives (National League for Nursing), 2005, v. 26, n. 5, p. 322
Publication type:: Article

Quick and easy way to monitor forecasts.

Published in:

1998

By:

Jain, Chaman L.

Publication type:

Editorial

New molecular entity.

Published in:: 2009
Publication type:: Product Review

FDA actions in brief.

Published in:: Formulary, 2008, v. 43, n. 6, p. 189
Publication type:: Article

New molecular entities.

Published in:: 2007
Publication type:: Product Review

FDA actions in brief.

Published in:: Formulary, 2007, v. 42, n. 6, p. 362
Publication type:: Article

New indications.

Published in:: 2006
Publication type:: Product Review

New molecular entities/new biologics.

Published in:: Formulary, 2003, v. 38, n. 8, p. 455
Publication type:: Article

Bristol-Myers Squibb.

Published in:: Formulary, 2000, v. 35, n. 10, p. 32
Publication type:: Article

NEWS AND PRODUCTS NOTES.

Published in:: Formulary, 1997, v. 32, n. 10, p. 1011
Publication type:: Article

SPONSORS OF AWARDS AT THE ANNUAL SCIENTIFIC MEETING.

Published in:: Nephrology, 2006, v. 11, p. iv, doi. 10.1111/j.1440-1797.2006.00658_3.x
Publication type:: Article

Ipilimumab: Melanoma and beyond.

Published in:

Journal of Pharmacy & Bioallied Sciences, 2011, v. 3, n. 4, p. 546, doi. 10.4103/0975-7406.90113

By:

Patel, Vishal;
Gandhi, Hardik;
Upaganlawar, Aman

Publication type:

Article

Mergers/Acquisitions.

Published in:: Applied Clinical Trials, 2005, v. 14, n. 9, p. 68
Publication type:: Article

Know your heart rate.

Published in:: 2013
Publication type:: Product Review

TGA approves metastatic melanoma drug.

Published in:: Australian Journal of Pharmacy, 2011, v. 92, n. 1096, p. 56
Publication type:: Article

Patent expiries in HIV -- Generics to take centre stage?

Published in:: Journal of Generic Medicines, 2005, v. 3, n. 1, p. 85, doi. 10.1057/palgrave.jgm.4940103
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2005, v. 16, n. 4, p. 8
Publication type:: Article

Aripiprazole approved for bipolar mania.

Published in:: Brown University Psychopharmacology Update, 2004, v. 15, n. 11, p. 8
Publication type:: Article

News Updates.

Published in:: Brown University Psychopharmacology Update, 2003, v. 14, n. 3, p. 7
Publication type:: Article

Black box warnings for droperidol and nefazodone.

Published in:: Brown University Psychopharmacology Update, 2002, v. 13, n. 1, p. 8
Publication type:: Article